Disease Landscape and Forecast Insights
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
- 1
- 2
Human Immunodeficiency Virus – Current treatment – Treatment Algorithms: Claims Data Analysis – Human Immunodeficiency Virus (US)
The human immunodeficiency virus (HIV) therapy market is crowded with many approved antiretroviral therapies (ARVs). Market growth is driven by the increasing acceptance of new, high-priced ARVs,…
Human Immunodeficiency Virus – Current treatment – Current Treatment: Physician Insights – Human Immunodeficiency Virus (US)
The human immunodeficiency virus (HIV) therapy market is dynamic and growing. With the launches of many effective antiretroviral therapies (ARTs), such as Gilead’s Biktarvy and ViiV’s Dovato,…
Human Immunodeficiency Virus | Treatment Algorithms: Claims Data Analysis | US | 2023
The HIV therapy market is crowded with many approved antiretroviral therapies (ARVs). Growth in this market is being driven by the increasing acceptance of new, high-priced ARVs, particularly the…
Human Immunodeficiency Virus | Treatment Algorithms: Claims Data Analysis | US | 2022
The HIV therapy market is crowded with many approved antiretroviral therapies (ARVs). Growth in this market is being driven by the increasing acceptance of new, high-priced ARVs, particularly the…
Human Immunodeficiency Virus – Geographic Focus: China – HIV – China In-Depth – China
China has a high disease burden of human immunodeficiency virus (HIV), but patients are well managed by different classes of antiretroviral therapies (ARTs), including single-tablet regimens (e.g…
Human Immunodeficiency Virus – Executive Insights – Human Immunodeficiency Virus Executive Insights
HIV is a deadly viral infection that impairs cells of the immune system and progressively destroys the body’s ability to fight infections. Availability of multiple therapeutic agents for…
- 1
- 2
